Search Login Register

Thrombocytopenia (Thrombopenia) Summary

Description: A subnormal level of BLOOD PLATELETS.

Also Known As: Thrombopenia; Thrombocytopenias; Thrombopenias

Networked: 18073 relevant articles (842 outcomes, 1156 trials/studies) for this Disease

Key Drugs and Agents for Thrombocytopenia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Heparin (Liquaemin) : 90 outcomes 174 studies in 3572 results : FDA 74 Generic
  2. Inosine Triphosphate (ITP) : 90 outcomes 136 studies in 1382 results : IBA
  3. Immunoglobulins (Immunoglobulin) : 35 outcomes 12 studies in 325 results : IBA
  4. Intravenous Immunoglobulins (IVIG) : 32 outcomes 16 studies in 173 results : FDA 1
  5. Antibodies : 28 outcomes 71 studies in 1162 results : IBA
  6. eltrombopag : 26 outcomes 35 studies in 150 results : FDA 1
  7. rituximab (Mabthera) : 25 outcomes 17 studies in 178 results : FDA 3
  8. Immunoglobulin G (IgG) : 24 outcomes 33 studies in 549 results : IBA
  9. Thrombopoietin (c-mpl Ligand) : 22 outcomes 49 studies in 272 results : IBA
  10. Adrenal Cortex Hormones (Corticosteroids) : 21 outcomes 8 studies in 149 results : IBA
Show All >>

Diseases Related to Thrombocytopenia

  1. Hemorrhage
  2. Anemia
  3. Leukopenia
  4. Neutropenia
  5. Infection
Show All >>

Key Therapies for Thrombocytopenia

Efficacy Chart >>
  1. Splenectomy : 81 outcomes 30 studies in 576 results
  2. Drug Therapy (Chemotherapy) : 69 outcomes 100 studies in 834 results
  3. Platelet Transfusion (Blood Platelet Transfusions) : 23 outcomes 36 studies in 494 results
  4. Plasma Exchange : 18 outcomes 1 study in 96 results
  5. Renal Dialysis (Hemodialysis) : 8 outcomes 5 studies in 132 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.